Pages that link to "Q33745071"

The following pages link to p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. (Q33745071):

Displaying 15 items.

• Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator (Q26825296) (← links)
• FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas (Q27679769) (← links)
• The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment. (Q30538230) (← links)
• Comprehensive pharmacological profiling of neurofibromatosis cell lines (Q33622690) (← links)
• Group I Paks as therapeutic targets in NF2-deficient meningioma (Q35273319) (← links)
• Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways (Q36247613) (← links)
• Vulvar malignancy in neurofibromatosis syndrome (Q37220286) (← links)
• Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1. (Q37688093) (← links)
• Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation (Q37880216) (← links)
• p21-activated kinase 1: PAK'ed with potential (Q37886485) (← links)
• PAK signaling in cancer (Q38060732) (← links)
• Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis. (Q38769437) (← links)
• P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma (Q39174795) (← links)
• Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe (Q40534803) (← links)
• Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer (Q57980063) (← links)